Simplified Chinese
Kangtai Biological has been named to the 2018 Top 10 Chinese Biopharmaceutical Companies list.
Release date:
2019-07-23
Author:
Source:
Abstract
On July 15, the “2018 China Top 100 Pharmaceutical Companies Series Rankings,” compiled by the Expert Committee of the China Top 100 Pharmaceutical Companies List, were released. Kangtai Biological ranked 7th on the “Top 20 Chinese Biopharmaceutical Enterprises (including blood products, vaccines, insulin, etc.)” list.

According to reports, the ranking was compiled by an expert committee and based on quantitative analysis using the Minenet database of the three major terminals and the six‑market terminal structure. It arrives at a scientific and rigorous assessment of pharmaceutical companies across two key dimensions: innovation-driven momentum and professional promotion capabilities.

Given that the core competitive factors vary across the major sub‑sectors of China’s pharmaceutical industry, a forced horizontal comparison is not feasible. In line with expert input, this ranking does not feature an overall list; instead, it comprises five specialized sub‑rankings: the “Top 100 Chinese Chemical Pharmaceutical Companies,” the “Top 100 Chinese Traditional Chinese Medicine Companies,” the “Top 20 Chinese CRO (including CDMO) Companies,” the “Top 20 Chinese Medical Device (including IVD) Companies,” and the “Top 20 Chinese Biopharmaceutical (including blood products, vaccines, insulin, etc.) Companies.”

Keywords:
Recommended Reading
Batch Release Status of the Company’s Products in 2026
2026-07-23
2026-07-15
2026-07-09